| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.90▲ | 2.86▲ | 2.86▲ | 2.97▼ | 2.79▲ |
| MA10 | 2.88▲ | 2.85▲ | 2.86▲ | 3.09▼ | 2.09▲ |
| MA20 | 2.86▲ | 2.84▲ | 2.87▲ | 2.60▲ | 1.80▲ |
| MA50 | 2.85▲ | 2.92▲ | 2.95▼ | 1.87▲ | 1.62▲ |
| MA100 | 2.83▲ | 2.97▼ | 2.89▲ | 1.70▲ | 3.86▼ |
| MA200 | 2.88▲ | 2.76▲ | 2.13▲ | 1.55▲ | 12.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.014▲ | 0.012▲ | -0.037▼ | 0.207▲ |
| RSI | 77.365▲ | 57.435▲ | 51.859▲ | 59.830▲ | 64.521▲ |
| STOCH | 92.360▲ | 43.791 | 58.388 | 30.976 | 59.366 |
| WILL %R | 0.000▲ | -20.513▲ | -12.903▲ | -45.740 | -37.253 |
| CCI | 142.161▲ | 127.722▲ | 128.695▲ | -41.767 | 99.184 |
| CDL | $ZNTL Engulfing Candlestick Pattern Detected | Set Alert |
|
Monday, November 24, 2025 02:52 AM
Zentalis Pharmaceuticals (ZNTL) is focused on developing azenosertib, a WEE1 inhibitor, for platinum-resistant ovarian cancer, with a pivotal DENALI Phase 2 trial ongoing. ZNTL stock has fallen over ...
|
|
Monday, October 13, 2025 09:06 AM
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class WEE1 inhibitor for ...
|
|
Wednesday, October 01, 2025 03:20 PM
SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/01/26 | 2.78 | 2.97 | 2.78 | 2.93 | 386,667 |
| 26/01/26 | 2.89 | 2.912 | 2.65 | 2.80 | 843,279 |
| 23/01/26 | 3.29 | 3.29 | 2.89 | 2.94 | 914,364 |
| 22/01/26 | 2.95 | 3.25 | 2.89 | 3.25 | 1,049,816 |
| 21/01/26 | 2.88 | 3.07 | 2.80 | 2.95 | 814,700 |
| 20/01/26 | 2.85 | 3.03 | 2.83 | 2.87 | 780,898 |
| 16/01/26 | 3.16 | 3.25 | 2.9325 | 2.96 | 1,194,543 |
| 15/01/26 | 3.50 | 3.55 | 3.155 | 3.16 | 1,392,000 |
| 14/01/26 | 3.46 | 3.56 | 3.34 | 3.51 | 1,098,400 |
| 13/01/26 | 3.37 | 3.61 | 3.33 | 3.48 | 1,647,800 |
|
|
||||
|
|
||||
|
|